IN THE NEWS

BOTHELL, WA – Cardiac Science Corporation, a global leader in advanced cardiac monitoring and defibrillation products, announced today that it has entered into a two-year marketing partnership with the City of Minneapolis.  Under the terms of the agreement, Cardiac Science will be the recommended provider of automated external defibrillators (AEDs) to participants in Minneapolis Project Heartbeat, the City’s public access defibrillation (PAD) program.  The agreement is renewable annually for three additional years.  

Minneapolis Project Heartbeat aims to increase the survivability of Sudden Cardiac Arrest (SCA) throughout the City of Minneapolis by making AEDs as common as fire extinguishers in city and county buildings, schools, businesses, and any public space in which a life can be saved. 

In the United States, more than 325,000 people die annually from SCA, the leading cause of death.  The key to surviving sudden cardiac arrest is the speed with which cardiopulmonary resuscitation (CPR) with defibrillation can be delivered to the victim.   In addition to CPR, most cardiac arrest victims need immediate defibrillation to restore the heart’s normal rhythm.  According to the American Heart Association, if a victim receives defibrillation within one minute of the SCA, there is a 90% chance of resuscitation.  If a victim must wait ten minutes for defibrillation, the chance of survival drops to less than 5%.

“By making the right tools and training widely available to the public, we aim to strengthen the average citizen’s ability to give the necessary, potentially life-saving aid to victims of   SCA, wherever it may occur,” said Charlotte Holt, Deputy Chief for Emergency Medical Services, Minneapolis Fire Department.  “Cardiac Science understands how PAD increases the likelihood of successful Emergency Medical Services intervention and our department is delighted to extend its relationship with the company.”

“The agreement provides us with an exciting opportunity to work with Minneapolis Fire and EMS and we are proud to be helping Minneapolis build more heart safe environments,” said Mike Brode, Cardiac Science’s Director of Strategic Business.  “We are equally proud to mark this agreement with the recent donation of a Powerheart® AED to Bloomington, Minnesota’s Holy Angels Academy in memory of Barry Delude, a firefighter with the Minneapolis Fire Department who recently passed away.  His son attends Holy Angels.” 

Under the terms of the agreement, four Minneapolis City firefighters will serve as coordinators of Minneapolis Project Heartbeat in their off-duty hours.  With their leadership, Cardiac Science and the City will actively promote the benefits of accessible defibrillation throughout the City at certain trade shows and health and safety events, as well as with direct mail, advertising and other methods.  

Minneapolis Project Heartbeat aims to provide businesses, government agencies, schools districts and others who oversee public spaces with the necessary resources to execute on-site, life-saving PAD programs successfully, easily, and affordably.  In practical terms, this includes:

• Medical oversight, including physician validation of training, standards, and procedures;
• Training in CPR and AED use;
• Program Maintenance, including record keeping and data collection;
• Consulting on site selection and deployment;
• Incident management;
• Protection against loss, damage or liability associated with an AED deployment; and
• Preferred pricing through Cardiac Science.

For more information, go to www.padprograms.com/minneapolis

Cardiac Science worked with the City of Minneapolis when it first launched its PAD program and deployed 32 Powerheart® AEDs in the Minneapolis Convention Center, City Hall, Public Service and City of Lakes Buildings. 

About Powerheart

Powerheart brand automated external defibrillators provide reliable, safe, and easy to use cardiac monitoring and defibrillation technology. Powerheart AEDs feature RHYTHMx™ software which detects abnormal heart rhythms, determines whether they are life-threatening, and only delivers a shock when needed. Powerheart AEDs also feature the patented RescueReady® technology, which automatically tests the device on a frequent basis to ensure continued functionality. Powerheart’s STAR® Biphasic Waveform Technology provides levels of escalating energy customized to the patient.  Powerheart AEDs are used by hospitals, police and fire departments, as well as many public access facilities including major corporations, public agencies, airlines and airports, arenas, schools, hotels, casinos and consumers. For more information about Powerheart, go to www.powerheart.com.

About Cardiac Science

Cardiac Science, a wholly owned subsidiary of Opto Circuits (India) Ltd., develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick^®, HeartCentrix^®, Powerheart^®, and Quinton^® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

Forward-Looking Statements

This press release contains forward-looking statements. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward-looking statements in this press release include, but are not limited to, those relating to Cardiac Science Corporation's future AED sales in Japan, expected shipments of backordered products in the fourth quarter of 2010, and expectations regarding the closing of the transaction with Opto Circuits. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results and performance may vary significantly from those expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks include those more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2009, as updated by subsequent quarterly reports on Form 10-Q. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

For updates and information on worldwide defibrillation and cardiac monitoring, find us on Facebook at http://facebook.com/cardiacscience, the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, and YouTube at http://budurl.com/CSonYT

For information, contact (media) Anastasia Mironova amironova@cardiacscience.com+1.425.402.2092 | (investors) ir@optoindia.com | +91.80.2852.8088 LOGO: http://www.cardiacscience.com/images/main_logo.gif